ClinicalTrials.gg
Not yet recruitingNCT07615140Updated Jun 2, 2026

Psychological Resilience, Perceived Stress and Periodontal Status Among Bruxers

An observational study in Periodontitis, Bruxism and Perceived Stress, sponsored by Postgraduate Institute of Dental Sciences Rohtak. Not yet recruiting at 1 site in India. Open to participants aged 30 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-06-02.

Sponsored by Postgraduate Institute of Dental Sciences Rohtak · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
75
Ages
30 Years to 50 Years
Sex
All
01

Study summary

The present study aims to evaluate psychological resilience as a modifier of the relationship between perceived stress and periodontal status among bruxers. Given that both stress and inflammation share common neuroendocrine and immunological pathways, resilience may play a crucial role in buffering stress-induced periodontal breakdown. Understanding this relationship could shift periodontal management toward a biopsychosocial model, integrating psychological assessment and resilience enhancement with conventional non-surgical therapy. Such insights could help design personalized periodontal care strategies addressing both biological and psychological determinants of disease progression.

Read the detailed description

Periodontitis has been defined by the 2018 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions as "a chronic multifactorial inflammatory disease associated with dysbiotic plaque biofilms and characterized by progressive destruction of the tooth supporting apparatus". The disease represents one of the most prevalent chronic conditions globally and is a leading cause of tooth loss in adults. The pathogenesis involves a complex interplay between microbial challenge, host immune-inflammatory responses, and modifying environmental, systemic and psychosocial factors. Although bacterial biofilm is a necessary etiological factor, it is the host response that determines disease progression or stability. Among several modifying influences, psychosocial stress has gained increasing attention in periodontal research. Chronic stress leads to sustained activation of the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic-adrenal-medullary system, resulted in elevated cortisol and cathecholamine. These neuroendocrine mediators exert profound effects on immune regulation, enhancing pro-inflammatory cytokine production, impairing neutrophil function, and delaying wound healing. In the periodontium, such dysregulation may potentiate tissue breakdown by amplifying inflammatory cascades and reducing reparative capacity.

Several studies have demonstrated a positive association between perceived psychosocial stress and periodontal disease severity, including increased probing depth, attachment loss, and bleeding on probing. Furthermore, stress can indirectly influence oral health through behavioral pathways such as poor oral hygiene, smoking, bruxism, and altered diet. Despite this, not all individuals exposed to similar stress levels exhibit equivalent periodontal destruction, indicating the presence of psychological moderators that buffer or modify stress effects.

One such factor is psychological resilience, defined as "a measure of stress-coping ability and a personal quality that enables one to thrive in the face of adversity".It reflects an individual's ability to maintain or regain mental health and functional stability despite adversity. Resilience is shaped by cognitive, emotional, and social components that promote adaptive coping and self-regulation. High resilience has been linked to better immune regulation, lower inflammatory markers such as C-Reactive protein and Interleukin-6, and faster recover from stress induced physiological changes.

Moreover, behavioural factors such as stress related parafunctional activity bruxism, characterized by repetitive jaw-muscle activity involving clenching or grinding of teeth and/or bracing or thrusting of the mandible. The excessive and repetitive forces associated with bruxism may exert traumatic effects on tooth supporting structures and are considered an important cofactor in the progression of periodontal breakdown.

Emerging evidence in behavioral medicine suggests that resilience can moderate the relationship between perceived stress and health outcomes, attenuating the physiological and behavioral impacts of chronic stress. In dentistry, however, this construct remains underexplored. No study have assessed how resilience interacts with stress to influence periodontal status among bruxers. Given that both stress and inflammation share common neuroendocrine and immunological pathways, resilience may play a crucial role in buffering stress-induced periodontal breakdown in bruxers.

Understanding this relationship could shift periodontal management toward a biopsychological model, integrating psychological assessment and resilience enhancement with conventional non-surgical therapy. Therefore, the present study aims to evaluate psychological resilience as a modifier of the relationship between perceived stress and periodontal status among bruxers. Such insights could help designed personalized periodontal care strategies addressing both biological and psychological determinants of disease progression.

02

Conditions studied

  • Periodontitis
  • Bruxism
  • Perceived Stress

Keywords

  • periodontitis
  • bruxism
  • stress
  • resilience
03

In context

Periodontitis

1,231 studies on the registry are indexed under Periodontitis; 295 are open to participants now.

This study's planned enrollment of 75 is below the median of 90 across 372 observational studies indexed under Periodontitis.

Browse Periodontitis studies →

Lead sponsor

Postgraduate Institute of Dental Sciences Rohtak is the lead sponsor of 213 studies on the registry; 72 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will be drawn from patients reporting to the outpatient clinic of department of Periodontics at PGIDS, Rohtak on the basis of strict inclusion and exclusion criteria

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with age group 30-50 years diagnosed with generalized periodontitis.
  • Probable bruxers (as per BruxScreen questionnaire)
  • Presence of minimum 20 teeth excluding third molars
  • Able to read/understand Hindi or English (for questionnaires)

Exclusion criteria

Exclusion Criteria:

  • Systemic diseases that may affect periodontal disease progression or outcome of treatment (diabetes, diseases)
  • History of Periodontal treatment within last 6 months
  • History of Antibiotic use within the previous 3 months
  • History of , and psychiatric drug use
  • Pregnant and lactating women
  • Smoking or substance abuse
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
75 participants (estimated)
Patient registry
No

Groups and cohorts

  • Probable Bruxers

    Patients aged 30-50 years with probable bruxism based on self report and clinical examination using Bruxscreen questionnaire. Participants underwent assessment of perceived stress using the perceived stress scale, pyschological resilience using Connor-Davidson Resilience scale, and periodontal health status via pocket probing depth, clinical attachment level, bleeding on probing, gingival index and plaque index.

    Other: Resilience assessment

Interventions

  • OtherResilience assessment

    Psychological resilience and perceived stress was assessed using questionaires

06

What researchers measure

Primary outcomes

  1. Psychological Resilience

    Participants will complete validated questionnaire using Connor-Davidson Resilience Scale (CD-RISC-10) to assess psychological resilience. 10 Items using 5-point Likert scale from 0 = not true at all to 4 = true nearly all the time. Minimum score:0, maximum score: 40. Higher score indicates greater psychological resilience.

    Time frame: Baseline

  2. Perceives Stress Scale

    Perceived stress scale will be assessed using perceived stress scale-10 item version questionnaire. 10 items using 5 point Likert scale 0= never to 4= very often. Minimum score: 0, maximum score: 40. Higher score indicate greater perceived stress.

    Time frame: baseline

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jun 2026; primary completion for Dec 2026, 6 months later.

How these figures are worked out, and which studies are left out of them.

Registered
May 22, 2026
First posted
May 29, 2026
StartEst.
Jun 21, 2026
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Jun 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07615140
Responsible party
Sponsor
First posted
May 29, 2026
Start date
Jun 21, 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jun 2, 2026

Study contacts

Gaytri, BDS
Contact
gaytrilalit901@gmail.com
+91 9991092061
Dr. Rajinder Kumar Sharma, MDS
Contact
rksharmamds@yahoo.in
+91 9416358222
Dr. Rajinder Kumar Sharma, MDS
study director · Post Graduate Institute of Dental Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion